Cookies Policy

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.

I accept this policy

Find out more here

In vitro inhalation behavior of spherically agglomerated steroid particles with carrier lactose

No metrics data to plot.
The attempt to load metrics for this article has failed.
The attempt to plot a graph for these metrics has failed.
The full text of this article is not currently available.

Brill’s MyBook program is exclusively available on BrillOnline Books and Journals. Students and scholars affiliated with an institution that has purchased a Brill E-Book on the BrillOnline platform automatically have access to the MyBook option for the title(s) acquired by the Library. Brill MyBook is a print-on-demand paperback copy which is sold at a favorably uniform low price.

This Article is currently unavailable for purchase.
Add to Favorites
You must be logged in to use this functionality

In order to prepare a dry powder inhalation (DPI) formulation for steroid KSR-592, we designed agglomerates consisting of fine primary drug particles suitable for inhalation by the spherical agglomeration method. The agglomerates easily disintegrated into the primary particles and were deposited on carrier lactose particles by use of a conventional agitation mixer in a short period, e.g. 2-10 min. The inhalation behavior of the DPI formulation evaluated with a twin impinger and a cascade impactor in vitro was determined by the mixing time of the agglomerated crystals with the carrier lactose particles. The DPI formulation prepared by mixing for 2 min showed the highest respirable fraction value compared with the formulations mixed for other lengths of time.


Full text loading...


Data & Media loading...

Article metrics loading...



Can't access your account?
  • Key

  • Full access
  • Open Access
  • Partial/No accessInformation